serrawettin w2 has been researched along with prodigiosin in 2 studies
Studies (serrawettin w2) | Trials (serrawettin w2) | Recent Studies (post-2010) (serrawettin w2) | Studies (prodigiosin) | Trials (prodigiosin) | Recent Studies (post-2010) (prodigiosin) |
---|---|---|---|---|---|
10 | 0 | 5 | 747 | 3 | 321 |
Protein | Taxonomy | serrawettin w2 (IC50) | prodigiosin (IC50) |
---|---|---|---|
Low molecular weight protein-tyrosine phosphatase A | Mycobacterium tuberculosis H37Rv | 8.8 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, F; Chen, T; Li, L; Li, Z; Liu, Y; Su, C; Sun, Y; Wen, X; Xiang, Z; Zhao, F; Zhao, X; Zhou, Y | 1 |
Clements, T; Khan, W; Ndlovu, T | 1 |
2 other study(ies) available for serrawettin w2 and prodigiosin
Article | Year |
---|---|
Analysis of the genomic sequences and metabolites of Serratia surfactantfaciens sp. nov. YD25
Topics: Anti-Bacterial Agents; Computational Biology; Data Mining; Fatty Acids; Genome, Bacterial; Genomics; Lipoproteins; Metabolome; Metabolomics; Multigene Family; Peptides, Cyclic; Phenotype; Phylogeny; Prodigiosin; Quorum Sensing; Serratia | 2016 |
Broad-spectrum antimicrobial activity of secondary metabolites produced by Serratia marcescens strains.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Depsipeptides; Lipoproteins; Methicillin-Resistant Staphylococcus aureus; Peptides, Cyclic; Prodigiosin; Pseudomonas aeruginosa; Secondary Metabolism; Serratia marcescens; Surface-Active Agents | 2019 |